{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:55:43Z","timestamp":1781308543029,"version":"3.54.1"},"reference-count":49,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the thromboembolic risk associated with oral estrogen is recognized, the risk profile of vaginal estrogen treatment remains inconclusive. This scoping review aims to explore available evidence on the association between vaginal estrogen treatment in postmenopausal women and the risk of thrombosis. We conducted a systematic search of PubMed and Embase, investigating vaginal estrogen treatment and thrombosis, for all records up to May 21, 2025. The process was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews (PRISMA-ScR) and a preregistered protocol (osf.io\/hgecd). We excluded systemic estrogen treatments, contraception, fertility treatments, gender-affirming therapies, and hormone treatments other than estrogen. Eligible study designs included clinical trials, randomized controlled trials, observational, case\u2013control, and cohort studies. The search identified 866 articles, whereof 8 were eligible. Manual searching through citations and references yielded 3 additional studies, resulting in 11 included articles, all observational. One study reported a reduced risk of recurrent myocardial infarction (MI) following discontinuation of vaginal estrogen treatment (adjusted hazard ratio [aHR]: 0.54; 95% confidence interval [CI]: [0.34\u20130.86]). Remaining studies found no thrombosis risk in vaginal estrogen users. For venous thromboembolism (n\u2009=\u20096), effect estimates ranged from null to reduced risk (aHRs: 0.68 [0.36\u20131.28], to 1.06 [0.58\u20131.93]), similar for MI (n\u2009=\u20095; aHRs: 0.52 [0.31\u20130.85] to 0.83 [0.77\u20130.89]) and stroke (n\u2009=\u20096, aHRs: 0.68 [0.62\u20130.70] to 0.96 [0.93\u20130.99]). This scoping review, including studies of generally moderate to high methodological quality, indicates no increased risk of thrombosis associated with vaginal estrogen use in postmenopausal women. Further prospective, high-quality clinical trials, including high-risk populations and women with prior thrombosis, are warranted.<\/jats:p>","DOI":"10.1055\/a-2882-1241","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:14:12Z","timestamp":1781306052000},"source":"Crossref","is-referenced-by-count":0,"title":["Is Vaginal Estrogen Treatment Associated with Risk of Thrombosis in Postmenopausal Women? A Scoping Review"],"prefix":"10.1055","author":[{"given":"Pinar","family":"Bor","sequence":"first","affiliation":[{"name":"Aarhus University Hospital, Central Denmark Region, Denmark","place":["Aarhus"],"department":["Department of Obstetrics and Gynaecology"]},{"name":"Aarhus Universitet, Central Denmark Region, Denmark","place":["Aarhus C"],"department":["Department of Clinical Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Vakur","family":"Bor","sequence":"first","affiliation":[{"name":"University of Southern Denmark, Region Syddanmark, Denmark","place":["Esbjerg"],"department":["Department of Regional Health Research, Thrombosis Research"]},{"name":"Esbjerg Central Hospital, Region Syddanmark, Denmark","place":["Esbjerg"],"department":["Department of Clinical Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6044-1620","authenticated-orcid":false,"given":"Sofie L.","family":"Juul","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Central Denmark Region, Denmark","place":["Aarhus"],"department":["Department of Obstetrics and Gynaecology"]},{"name":"Aarhus Universitet, Central Denmark Region, Denmark","place":["Aarhus C"],"department":["Department of Clinical Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Glavind-Kristensen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Central Denmark Region, Denmark","place":["Aarhus"],"department":["Department of Obstetrics and Gynaecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJWH.S158913","article-title":"Current treatment options for postmenopausal vaginal atrophy","volume":"10","author":"I Naumova","year":"2018","journal-title":"Int J Womens Health"},{"issue":"07","key":"ref2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 Hormone Therapy Position Statement of the North American Menopause Society","volume":"29","author":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel","year":"2022","journal-title":"Menopause"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: A bench to bedside review","volume":"192","author":"M Y Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"issue":"7655","key":"ref4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"M Canonico","year":"2008","journal-title":"BMJ"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GME.0000000000000296","article-title":"Hormone therapy and hemostasis among postmenopausal women: a review","volume":"21","author":"M Canonico","year":"2014","journal-title":"Menopause"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"J E Manson","year":"2013","journal-title":"JAMA"},{"issue":"03","key":"ref7","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"H MP Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study","volume":"115","author":"M Canonico","year":"2007","journal-title":"Circulation"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: A systematic review","volume":"307","author":"M\u0160 Gold\u0161tajn","year":"2023","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: An Endocrine Society Clinical Practice Guideline","volume":"100","author":"C A Stuenkel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"R J Santen","year":"2020","journal-title":"Menopause"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits","volume":"52","author":"M G Modena","year":"2005","journal-title":"Maturitas"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"R Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"M Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: A cross-over study","volume":"123","author":"K Fleischer","year":"2009","journal-title":"Thromb Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2023.04.271","article-title":"Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice","volume":"174","author":"P Stute","year":"2023","journal-title":"Maturitas"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"J E Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial","volume":"291","author":"G L Anderson","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jamainternmed.2025.4510","article-title":"Menopausal hormone therapy and cardiovascular diseases in women with vasomotor symptoms: A secondary analysis of the Women's Health Initiative Randomized Clinical Trials","volume":"185","author":"J E Rossouw","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.2025.22259","article-title":"Updated labeling for menopausal hormone therapy","volume":"335","author":"M A Makary","year":"2026","journal-title":"JAMA"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"A C Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bcpt.13644","article-title":"Does administration of vaginal estrogens increase the risk of venous thromboembolism: A case-control study","volume":"129","author":"A LO Svendsen","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ejh.14287","article-title":"Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case-control study","volume":"113","author":"C Eckert-Lind","year":"2024","journal-title":"Eur J Haematol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study","volume":"25","author":"C J Crandall","year":"2018","journal-title":"Menopause"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/STROKEAHA.117.017132","article-title":"Risk of stroke with various types of menopausal hormone therapies: A national cohort study","volume":"48","author":"E L\u00f8kkegaard","year":"2017","journal-title":"Stroke"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/GME.0000000000002335","article-title":"Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses","volume":"31","author":"S H Baik","year":"2024","journal-title":"Menopause"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/GME.0000000000001284","article-title":"Vaginal estrogen use and chronic disease risk in the Nurses' Health Study","volume":"26","author":"S N Bhupathiraju","year":"2018","journal-title":"Menopause"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/humrep\/dew014","article-title":"Vaginal estradiol use and the risk for cardiovascular mortality","volume":"31","author":"T S Mikkola","year":"2016","journal-title":"Hum Reprod"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/eurheartj\/ehn408","article-title":"Hormone therapy and risk of myocardial infarction: A national register study","volume":"29","author":"E L\u00f8kkegaard","year":"2008","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Y Vinogradova","year":"2019","journal-title":"BMJ"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"e1002445","DOI":"10.1371\/journal.pmed.1002445","article-title":"Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies","volume":"14","author":"G D Carrasquilla","year":"2017","journal-title":"PLoS Med"},{"issue":"7851","key":"ref33","doi-asserted-by":"crossref","first-page":"e1802","DOI":"10.1136\/bmj.e1802","article-title":"Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: Nationwide cohort study","volume":"344","author":"D M Bretler","year":"2012","journal-title":"BMJ"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1038\/s41598-020-77534-9","article-title":"A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases","volume":"10","author":"J E Kim","year":"2020","journal-title":"Sci Rep"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.7326\/ANNALS-24-00610","article-title":"Hormonal treatments and vaginal moisturizers for genitourinary syndrome of menopause: A systematic review","volume":"177","author":"E R Danan","year":"2024","journal-title":"Ann Intern Med"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/GME.0000000000001468","article-title":"Safety of vaginal estrogens: A systematic review","volume":"27","author":"C J Crandall","year":"2020","journal-title":"Menopause"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GME.0000000000001221","article-title":"A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause","volume":"26","author":"C Biehl","year":"2019","journal-title":"Menopause"},{"issue":"08","key":"ref38","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"A Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","article-title":"Vaginal estrogen for genitourinary syndrome of menopause: A systematic review","volume":"124","author":"D D Rahn","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001938","article-title":"Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: A scoping review","volume":"29","author":"T H Sobel","year":"2022","journal-title":"Menopause"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: A systematic review","volume":"25","author":"C Oliver-Williams","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ncl.2008.07.003","article-title":"Epidemiology of ischemic and hemorrhagic stroke: Incidence, prevalence, mortality, and risk factors","volume":"26","author":"R A Grysiewicz","year":"2008","journal-title":"Neurol Clin"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2020.05.034","article-title":"Vaginal estrogen-what a urologist should know?","volume":"151","author":"C Escobar","year":"2021","journal-title":"Urology"},{"issue":"07","key":"ref44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14656566.2019.1574752","article-title":"Pharmacotherapy for the treatment of vaginal atrophy","volume":"20","author":"G GG Donders","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2021.04.005","article-title":"Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide","volume":"148","author":"A L Hirschberg","year":"2021","journal-title":"Maturitas"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"101789","DOI":"10.1016\/j.beem.2023.101789","article-title":"Oestrogen-based therapies for menopausal symptoms","volume":"38","author":"A Laing","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jmwh.13277","article-title":"Genitourinary syndrome of menopause","volume":"66","author":"J M Marino","year":"2021","journal-title":"J Midwifery Womens Health"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/GRF.0000000000000358","article-title":"Management of menopausal symptoms for women who are at high risk of thrombosis","volume":"61","author":"J V Pinkerton","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2005-869480","article-title":"Vaginal hormone therapy for urogenital and menopausal symptoms","volume":"23","author":"S A Ballagh","year":"2005","journal-title":"Semin Reprod Med"},{"issue":"S 02","key":"ref50","first-page":"S74","article-title":"Postmenopausal hormone therapy-local and systemic: A pharmacologic perspective","volume":"60","author":"T Smith","year":"2020","journal-title":"J Clin Pharmacol"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2882-1241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:14:22Z","timestamp":1781306062000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2882-1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1055\/a-2882-1241","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}